• HSBC

Indo Gulf participates in Duphat

  • United Arab Emirates: Tuesday, May 12 - 2009 at 12:29
  • PRESS RELEASE

Serum Indo Gulf recently participated in the 14th edition of "Dubai international Pharmaceutical and Technologies" conference sponsored by Dubai Health Authority.

Duphat is a gathering of more than 288 exhibitors from all over the world, there were more than 9000 visitors, and takes an important event for the pharmaceutical professionals

The Duphat attended from Serum Indo Gulf side by, Dr.Abeer Shoukry, the manager and the pharmacist in charge of Serum Indo Gulf, Mr. V R Patil, the export director of Serum Institute Of India, Mrs. Anita, assistant manager in Serum Institute Of India.

Amna Binhendi, the CEO of Indo gulf, said that:
"It was important for us to participate in Duphat that had been held on 2009. Being part of Duphat is an opportunity for Serum INDO Gulf to be recognized and to reach the Europe, Middle East, GCC Countries and Asia through UAE Market."


She added: "It is indeed privilege for us to contribute and be part of an industry that caters million of people for a better health - better life through UAE Market. It IS Indeed privilege for us to contribute and be part of an industry that caters million of people for a better health and better life".

From the other hand she emphasized on that the Duphat is a unique opportunity, which gathers the pharmaceutical professionals and important pharmaceutical trader from all over the world especially the GCC countries so it allowed us to introduce ourselves and meet many of the opinion leaders and decisions makers of the pharmaceutical field in the UAE and other GCC countries.

It is important here to point at that; Serum Institute products combine the highest quality plus the competitive price which is far better than its competitor. Therefore, this important factor play a major role in making Indo gulf products the ideal choice for the present situation.

Indo Gulf is the exclusive distributer of Serum Institute of India that has been operating in the UAE market since 2005 and launched in 2008, and it is responsible also for the registration of the company products in Ministry Of Health, promotion and sales.

One of the most important factors that lie behind choosing the UAE as launching point to progressively cover and spread the GCC market is that the UAE is a fast growing market especially the vaccines sector industry.
During the event.
During the event.
Enlarge »
Article Options
Log in to request more information

Notes and Media Contacts »

Serum Indo Gulf is a joint venture between Binhendi Enterprises headed by the Mr. Binhendi and Serum Institute of India which is one of the biggest manufacturers of vaccines and anti serum products as well as anti cancer headed by Mr. Poonawalla.

Disclaimer »

Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com

Any opinions, advice, statements, offers or other information expressed in this section of the AMEinfo.com Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / Emap Limited. AME Info FZ LLC / Emap Limited is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AMEinfo.com Web site.

For details about submitting your stories, please read the guide - all content published is subject to our terms and conditions